Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer.
Reckamp
Karen
K
City of Hope Comprehensive Cancer Center, Duarte, California, USA. kreckamp@coh.org
Gitlitz
Barbara
B
Chen
Lin-Chi
LC
Patel
Ravi
R
Milne
Ginger
G
Syto
Mary
M
Jezior
Deborah
D
Zaknoen
Sara
S